New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
As the body ages, cells naturally accumulate dozens of genetic mutations each year. New research from Boston Children's Hospital, published in Cell, finds that the brain's resident immune cells, ...
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
Rezetapopt demonstrated a 44.4% overall response rate and durable responses lasting over eight months in patients with ...
Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...
Some 17 million Americans are living with genetic mutations tied to an increased risk of getting cancer, Cleveland Clinic researchers warned Monday. And the more than 3,400 mutations identified – ...
The free lodging, meals, and support Duane received as a guest at Hope Lodge Baltimore made it possible for him to take part ...
New research from Boston Children’s Hospital, published in Cell, finds that the brain’s resident immune cells, microglia, ...
Results from two early-stage trials offer new hope for a cancer that kills around one in eight patients within five years.
Around 60,000 people are diagnosed with pancreatic cancer each year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results